Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Gussago
Clinical trial register · Italy

Clinical Trials in Gussago, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 2855 Bologna 1282 Roma 1266 Naples 983 Rome 968

Trials with a site in Gussago

11 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
NCT07486934Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy, Steinert Disease
Dyne Therapeutics
Phase 3
150
Gussago, Milan, Roma
2026-05-14
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
argenx
Phase 3
160
Gussago, Trieste, Bologna, Genova, Milan, Naples, Pavia
2025-09-16
Recruiting
Dianthus Therapeutics
Phase 3
256
Bergamo, Bologna, Genova, Gussago, Milan, Modena, Monza, Pavia
2025-02-10
Active, closed
argenx
Phase 3
154
Florence, Genova, Gussago, Messina, Milan, Roma, Rozzano
2024-12-18
Recruiting
Istituto Giannina Gaslini
Observational
200
Bologna, Bosisio Parini, Conegliano, Genova, Gussago, Messina, Milan, Naples
2024-04-11
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Gussago, Milan, Pisa, Roma
2024-03-04
Active, closed
Astellas Gene Therapies
Not applicable
119
Florence, Gussago, Messina, Milan, Pavia, Pisa, Roma, Udine
2024-02-01
Active, closed
argenx
Observational
413
Florence, Gussago, Messina, Novara, Orbassano, Palermo, Pavia, Pisa
2023-11-29
Active, closed
Biohaven Pharmaceuticals, Inc.
Phase 3
269
Bologna, Gussago, Pavia, Roma
2022-07-06
Recruiting
AB Science
Phase 3
495
Baggiovara, Brescia, Gussago, Milan, Novara, Padova, Pavia, Torino
2021-02-02
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Gussago, Cona, Florence, Genoa, Milan, Padua, Rome, Brescia
2004-09-15
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-italy/city/gussago

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Gussago.

How many clinical trials are recruiting in Gussago?

6 of the 11 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gussago), 11 studies
PhaseStudiesRecruitingShare
Phase 36454.5%
Observational3227.3%
Not applicable109.1%
Phase 1/2109.1%

Most active sponsors

Lead sponsors with the most studies (Gussago)
Lead sponsorStudiesRecruiting
argenx31
AB Science11
Astellas Gene Therapies10
Biohaven Pharmaceuticals, Inc.10
Dianthus Therapeutics11
Dyne Therapeutics11
Genzyme, a Sanofi Company11
Istituto Giannina Gaslini11
Sarepta Therapeutics, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.